SMTL ID : 7vs1.1

crystal structure of BRD2-BD2 in complex with purine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.25 Å

Oligo State

homo-dimer

Ligands

2 x 7UM: 3-methyl-7-propyl-purine-2,6-dione(Non-covalent)

7UM.1: 6 residues within 4Å: Chain A: P.31, V.36, L.41, N.89, H.93, V.95 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.89, A:N.89 7UM.3: 6 residues within 4Å: Chain B: P.31, V.36, L.41, N.89, H.93, V.95 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.89, B:N.89

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 5 residues within 4Å: Chain A: Y.28, D.94, A.97, M.98, K.101 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.101, A:K.101 Water bridges: A:D.94 GOL.4: 5 residues within 4Å: Chain B: Y.28, D.94, A.97, M.98, K.101 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:K.101, B:K.101 Water bridges: B:D.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arole, A.H. et al., Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol (2023)

Release Date

2023-02-01

Peptides

Bromodomain-containing protein 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Bromodomain-containing protein 2